BSECompany Update5d ago · 14 Aug 2026, 05:59 pm
Pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 162A of SEBI (Issue of ....
Kilburn Engineering Ltd · 522101
✦ AI SummaryFundraise
Kilburn Engineering Ltd has submitted a Monitoring Agency Report for the first quarter ended June 30, 2026, as per SEBI regulations, detailing the utilization of proceeds from a preferential issue of Rs. 290.65 crore.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk3/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Kilburn Engineering Ltd - 522101 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Attachments (1)
📄pdf
Download →
2a18cf80-c667-4b1f-ab4f-5968ad4fb3fc.pdf
View document text
Date : 14th August, 2026
The Corporate Relationship
Department
BSE Limited
P.J. Tower
Dalal Street, Fort
Mumbai - 400 001
Scrip Code: BSE 522101
Sub: Monitoring Agency Report for the first quarter ended 30th June, 2026
Pur suant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 read with Regulation 162A of SEBI (Issue of Capital and Disclosure
Requirements) Regulations, 2018, enclosed herewith the Monitoring Agency Report for the
first quarter ended 30th June, 2026, issued by Care Ratings Limited, Monitoring Agency,
appointed to monitor the utilisation of proceeds of the funds raised through preferential issue.
We request you to take the same on your record.
For Kilburn Engineering Limited
Abhijit Mehta
Company Secretary & Compliance Officer
Encl :A/a
No. CARE/KRO/GEN/2026-27/1071
The Board of Directors
Kilburn Engineering Limited
Plot No-6, Kalyan Bhiwandi Road
Saravali, Thane
Maharashtra, 421311
August 14, 2026
Dear Sir/Ma’am,
Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the Preferential Issue of Kilburn
Engineering Limited (“the Company”)
We write in our capacity of Monitoring Agency for the Preferential Issue for the amount aggregating to Rs. 290.65 crore
(revised from Rs. 299.63 crore) of the Company and refer to our duties cast under Regulation 162A of the Securities &
Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations.
In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026, as per aforesaid
SEBI Regulations and Monitoring Agency Agreement dated August 27, 2024.
Request you to kindly take the same on records.
Thanking you,
Yours faithfully,
Kamal Mahipal
Associate Director
Kamal.Mahipal@careedge.in
CARE Ratings Limited
Unit No. A/7/4, 7th Floor Block A, Apeejay House, 4th Floor, Godrej Coliseum, Somaiya Hospital
15 Park Street, Kolkata – 700016 Road, Off Eastern Express Highway, Sion (East),
Phone: +91-33-4018 1600/2283 1803 Mumbai - 400 022
Phone: +91-22-6754 3456 • www.careedge.in
CIN-L67190MH1993PLC071691
Report of the Monitoring Agency
Name of the issuer: Kilburn Engineering Limited
For quarter ended: June 30, 2026
Name of the Monitoring Agency: CARE Ratings Limited
(a) Deviation from the objects: Nil
(b) Range of Deviation: Not Applicable
Declaration:
We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects
of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be
accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/
certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA
which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and
opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner
whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship
between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not
act as an expert as defined under Section 2(38) of the Companies Act, 2013.
The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report
pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that
there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue
proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity.
We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where
applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be
captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting
their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been
reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board.
Signature:
Name and designation of the Authorized Signatory: Kamal Mahipal
Designation of Authorized person/Signing Authority: Associate Director
CARE Ratings Limited
Unit No. A/7/4, 7th Floor Block A, Apeejay House, 4th Floor, Godrej Coliseum, Somaiya Hospital
15 Park Street, Kolkata – 700016 Road, Off Eastern Express Highway, Sion (East),
Phone: +91-33-4018 1600/2283 1803 Mumbai - 400 022
Phone: +91-22-6754 3456 • www.careedge.in
CIN-L67190MH1993PLC071691
1) Issuer Details:
Name of the issuer : Kilburn Engineering Limited
Name of the promoter : Firstview Trading Private Limited, Williamson Magor & Co. Limited and Khaitan Family.
Industry/sector to which it belongs : Manufacturing
2) Issue Details
Issue Period : November 16, 2024, and November 19, 2024
Type of issue (public/rights) : Preferential Issue
Type of specified securities : Equity shares and Convertible warrants
IPO Grading, if any : Not Applicable
Issue size (in crore) : Rs.290.65 crore (revised from Rs. 299.63 crore)
3) Details of the arrangement made to ensure the monitoring of issue proceeds:
Source of information / certifications
Comments of the Comments of the
Particulars Reply considered by Monitoring Agency for
Monitoring Agency Board of Directors
preparation of report
Due to forfeiture of 235,000 Due to forfeiture of 235,000
convertible warrants on account of convertible warrants on account of
non-payment of balance 75% of the non-payment of balance 75% of the
warrant subscription (due date of May warrant subscription (due date of May
15, 2026) and non-subscription of 15, 2026) and non-subscription of
35,000 equity shares under preferential 35,000 equity shares under preferential
issue, the total issue size has been issue, the total issue size has been
AGM resolution dated September 20, revised from Rs.299.63 crore to revised from Rs.299.63 crore to
Whether all utilization is as per the disclosures in the 2024, Board Resolution dated May 26, Rs.290.65 crore as per Board Rs.290.65 crore as per Board
Offer Document? 2026, Management certificate, Statutory Resolution dated May 26, 2026. Resolution dated May 26, 2026.
Auditor’s certificate*. Accordingly, the allocation amount Accordingly, the allocation amount
towards General Corporate Purposes towards General Corporate Purposes
has been revised from Rs 74.00 crore to has been revised from Rs 74.00 crore to
Rs 65.02 crore. Rs 65.02 crore.
As per the revised cost of objects Board As per the revised cost of objects
Resolution dated May 26, 2026, the Board Resolution dated May 26, 2026,
utilization of funds is as per revised the utilization of funds is as per revised
objects. objects.
Whether shareholder approval has been obtained in Not Applicable Management certificate Not Applicable NA
CARE Ratings Limited
Unit No. A/7/4, 7th Floor Block A, Apeejay House, 4th Floor, Godrej Coliseum, Somaiya Hospital
15 Park Street, Kolkata – 700016 Road, Off Eastern Express Highway, Sion (East),
Phone: +91-33-4018 1600/2283 1803 Mumbai - 400 022
Phone: +91-22-6754 3456 • www.careedge.in
CIN-L67190MH1993PLC071691
Source of information / certifications
Comments of the Comments of the
Particulars Reply considered by Monitoring Agency for
Monitoring Agency Board of Directors
preparation of report
case of material deviations# from expenditures
disclosed in the Offer Document?
As explained above, the means of As explained above, the means of
finance for the disclosed objects of the finance for the disclosed objects of the
issue have been changed due to the issue have been changed due to the
AGM resolution dated Septem
[Showing first 8,000 characters — download PDF for full document]